Follow us...

 

Search News Archives

News Channels

 

Coronavirus (COVID-19)

 

 

View Channel

New Laboratory Products

 

View Channel

Lab News

 

View Channel

Research & Case Studies

 

View Channel

Microscopy | Image Analysis

 

View Channel

Separation Science

 

View Channel

Videos

 

View Channel

Events | Webinars

 

View Channel

Conferences | Events
Kerafast

Kerafast

Kerafast

Products

Contact Kerafast


If you have not logged into the website then please enter your details below.

All articles from Kerafast

  Kerafast Offers the Delta-G-VSV Pseudotyping System for Coronavirus Research

Kerafast Inc., developers of an online platform to facilitate access to unique lab-made bioresearch materials, today announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, developed by the Michael Whitt laboratory at University of Tennessee, enables studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) containment....

 

  Kerafast Partners with The Good Food Institute to Facilitate Access to Cell Lines for Developing Sustainable Meat and Seafood

Kerafast Inc., developers of an industry-leading online platform to facilitate access to unique lab-made bioresearch materials, has announced an agreement with The Good Food Institute, a nonprofit organization committed to making cultivated and plant-based meat and seafood a reality. Under the partnership, terrestrial meat and aquatic cell lines will be made available to scientists worldwide via Kerafast’s online catalog, providing valuable research tools for the development of sustainable meat and seafood as alternatives to animal products.

 

  Absolute Antibody Receives ISO 9001:2015 Certification for Recombinant Antibody Manufacturing Facility

Absolute Antibody Ltd., an industry-leading manufacturer of recombinant antibodies, announces its manufacturing facility based in Wilton Centre, Redcar, England has been certified under ISO 9001:2015 as of December 17, 2018. The newly expanded, state-of-the-art facility was designed with a focus on the standards to provide customers and distributors with the highest level of quality. International Organization for Standardization (ISO) 9001:2015 is the most updated standard of its kind...

 

  Absolute Antibody and Kerafast Merge to Increase Access to Unique Reagents and Recombinant Antibody Technology

Absolute Antibody Ltd., an Oxford, UK-based company with a vision to make recombinant antibody technology accessible to all, and Kerafast Inc., a Boston, MA-based company with a mission to facilitate access to unique laboratory-made reagents, today announced a merger of the two companies. The merger brings together two companies with a shared commitment to improving the selection of research tools available to the scientific community....

 

  Kerafast Celebrates 5 Years of Facilitating Access to Research Reagents

Start-up company now partners with 140+ prominent research institutions

kerafast logoKerafast Inc., developers of an industry-leading online platform to facilitate accessibility to unique bioresearch materials from laboratories across the globe, is celebrating its five-year anniversary this December. Since its founding in December 2011, Kerafast has partnered with more than 140 prominent academic institutions to facilitate access to research tools....

 

  Kerafast Expands List of International Providing Institutions

Key partners add to growing list of academic institutions making reagents available

KerafastKerafast Inc., developers of an online platform to facilitate accessibility to unique bioresearch materials from laboratories across the globe, today announced an increase in the number of international institutional laboratories adding reagents and services to its catalog....

 

  Kerafast adds new Zika virus antibody to its catalog of novel life science reagents

Company aims to help accelerate progress toward a vaccine or treatment for this global health threat

Anti-Zika Virus Envelope (E) Protein AntibodyKerafast Inc., developers of an online platform that facilitates accessibility to unique bioresearch materials from laboratories across the globe, today announced the availability of a Zika virus antibody from Vanderbilt University. While researchers scramble to increase the pace of research toward treatment and prevention measures for the Zika virus, the virus’s geographical distribution continues to widen during this epidemic.

 

  Kerafast Partners with the National Cancer Institute (NCI) - Enables Sharing of NCI Research Materials through Kerafast Platform

Partnership seeks to advance scientific discovery by offering important bioreagents

Kerafast Inc., developers of an online platform to facilitate accessibility to unique bioresearch materials from academic and government laboratories across the globe, today announced an agreement to make important research materials from the National Cancer Institute available through Kerafast’s platform. With this agreement, Kerafast has now partnered with 122  institutes....

 

 

 

 

Media Partners